Yesterday morning the IAS organizing committee released the following message:
The International AIDS Society (IAS) today expresses its sincere sadness at receiving news that a number of colleagues and friends en route to attend the 20th International AIDS Conference taking place in Melbourne, Australia, were on board the Malaysian Airlines MH17 flight that has crashed over Ukraine earlier today.
At this incredibly sad and sensitive time the IAS stands with our international family and sends condolences to the loved ones of those who have been lost to this tragedy.
Many of the passengers aboard the Malaysia Airlines flight that crashed in eastern Ukraine on Thursday were World Health Organization staffers heading to a conference on AIDS research in Australia, the Guardian reported.
Our current technological era, submerged by continuous discoveries and breakthroughs, has developed an appropriately new award: The Breakthrough Prize.
The motivation of such new award is well described at its webpage
Knowledge is humanity’s greatest asset. It defines our nature, and it will shape our future. …… The disciplines that ask the biggest questions and find the deepest explanations are the fundamental sciences. The Breakthrough Prizes honor important, primarily recent, achievements in the categories of Fundamental Physics, Life Sciences and Mathematics. The prizes were founded by Sergey Brin and Anne Wojcicki, Mark Zuckerberg and Priscilla Chan, and Yuri and Julia Milner. Committees of previous laureates choose the winners from candidates nominated in a process that’s online and open …
Interview with Dr. Robert C. Gallo, MD, Director of the Institute of Human Virology at the University of Maryland School of Medicine and Scientific Director of the Global Virus Network
Before AIDS you were researching the first known human retroviruses, and the only known virus to cause leukemia. Did you find cancer or AIDS research more challenging?
They are both about the same. Only cancer is more complicated because it includes many different diseases. With AIDS you can pour yourself into one, single, unifying cause – HIV – so there is a chance of really doing something about it in total. Whereas in cancer you have to treat each type of cancer as a singular different …
Selected EMBLEM investigators joined more than 1000 scientists from 66 countries (including 32 of the 54 countries in Africa) in Durban, South Africa to participate in the ninth biannual meeting of the African Organization for Research and Training in Cancer (AORTIC) from November 21st to 24th, 2013. Held in the historic Albert Luthuli International Convention Center, the theme of the meeting was “Cancer in Africa: Bridging Science and Humanity”.
The meeting, one of the best organized by AORTIC, included plenary and workshop sessions with up to five concurrent sessions covering epidemiology, pathogenesis, molecular studies and innovative therapeutic strategies. The meeting had a strong emphasis on capacity building, including presentations from two cohorts of the BIG CAT grants from the National Cancer …
The 6th National Conference of AIDS Society of India (ASICON) has been held December 13th through 15th at the Palladium Hotel (former Shangri-La Hotel), a luxurious hotel located in the heart of the city, within the residential and corporate hub of Lower Parel, above the Palladium, Mumbai’s most luxurious mall.
The Conference, with contribution of 14 International and 58 national speakers articulated in 24 plenary sessions, discussion forums, workshops, abstract & poster sessions.
ASICON 2013 has been a unique opportunity for scientific update and a quality gathering of HIV care givers and scientists. Presentations and the following discussions will likely contribute to enhance the quality of HIV care and prioritize research issues in India, in particular to review and reflect …
The recent AORTIC (The African Organization for Research and Training in Cancer) Meeting held in Durban at the ICC (International Conference Center) on 21-24th November has been a relevant scientific event gathering more than 1000 scientists from 66 Countries (including 32 of the 52 countries in Africa).
The well organized meeting has been articulated in plenary and workshop sessions with up to 5 concurrent parallel sessions, spanning from epidemiological analyses to pathogenic mechanisms, biomolecular pathways, clinical data, innovative therapeutic strategies. The Meeting besides focusing on specific African oncologic issues, which needs to be properly addressed, plays a major role in the formation of a young generation of African oncologists. They will need to be ready to …
As low- and middle- income countries (LMICs) continue to face health challenges from infectious disease, they are concurrently challenged by the rising burden of non-communicable diseases including cancer. Changing economics in many countries around the world have meant changes in dietary and behavioral factors, several of which are linked to increased risk for cancers.
Collaborative partnerships between a combination of low-, middle- and upper -income country cancer centers may provide a roadmap for improving cancer prevention and control capacity in low-resource settings.
In order to make information and lessons-learned about successful cancer centers and the management of cancers in LMICs more broadly available and to help re-invigorate efforts to build partnerships and provide important information for those seeking to replicate successful …
Cases of certain HPV strains have plunged 56 percent among females 14 years old to 19 years old since the first vaccine, Merck & Co. (MRK)’s Gardasil, was introduced in 2006, according to an article yesterday in the Journal of Infectious Diseases. The shot is 82 percent effective against the virus that can cause cervical cancer if at least one of the three doses is given.
“These are striking results and they should be a wake-up call that we need to increase vaccinations,” Thomas Frieden, director of the Centers for Disease Control and Prevention, told reporters on a conference call. “It is possible to protect a generation from cancer and we have to do it.”
A vaccine for human papillomavirus, a …
Lyon, France, 21 May 2013 – The International Agency for Research on Cancer (IARC) has the pleasure of announcing the re-election of Dr Christopher Wild as Director of this specialized cancer research agency of the World Health Organization (WHO). The IARC Governing Council, made up of representatives of 24 Participating States plus the Director-General of WHO, reappointed Dr Wild for a second five-year term at its annual meeting in Lyon on May 16–17, 2013.
“I have had the honour and privilege to lead IARC for five years, and I look forward to taking up the challenges posed by the markedly increasing number of cancer cases globally,” said Dr Wild. “The particularly heavy burden projected to fall on the low- and middle-income …
Global Health programs are key goals of many internationally oriented Health Institutes and Organizations, and within such approach a Global Oncology program will become a major, crucial objective.
Infectious diseases are in general under control (with some emerging and re-emerging episode), life expectancy is globally increasing, and incidence as well as disease-burden of cancers (associated or not to infectious agents) will be inevitably rising. We need to develop the new clinical oncology of tomorrow and to prepare the next generation of oncologists. The aims of the section and the call for the papers is currently highlighted at the BioMed Central Blog